NCT04194385

Brief Summary

Interscalene brachial plexus block is known as the gold standard for analgesia after shoulder surgery, but limits the use of ipsilateral phrenic nerve paralysis. Recently, interest in potential diaphragm-sparing alternative blocks has increased for patients undergoing shoulder surgery.Two of these blocks are upper trunk block (UTB) and costoclavicular brachial plexus (CCBPB) block. This randomized controlled trial will compare ultrasound-guided UTB and CCBPB in patients undergoing arthroscopic shoulder surgery. The main outcome is pain intensity score at 30 minutes after arrival in the post anesthesia care unit (PACU) as measured by a numerical rating scale (NRS) from 0 to 10. The investigators research hypothesis is that UTB and CCBPB will result in equivalent postoperative analgesia at 30 minutes in the PACU.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 11, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

May 10, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

April 5, 2023

Status Verified

April 1, 2023

Enrollment Period

3 years

First QC Date

December 9, 2019

Last Update Submit

April 4, 2023

Conditions

Keywords

bupivacainecostoclavicular blockupper trunk block

Outcome Measures

Primary Outcomes (1)

  • Detection of diaphragmatic paralysis by ultrasonography

    Ipsilateral diaphragmatic excursion 30 minutes after block completion

    30 minutes after block application

Secondary Outcomes (6)

  • Postoperative opioid consumption

    24 hour after surgery

  • Pain intensity score

    30 minutes, 1,3, 6, 12, 24 hour after surgery

  • Block perform time

    The time from the needle enters the skin until the block is completed

  • Block onset time

    Until sensory and motor block occurs

  • Intraoperative fentanyl requirement

    From the beginning to the end of the operation

  • +1 more secondary outcomes

Study Arms (2)

Upper trunk block

ACTIVE COMPARATOR

In the supraclavicular region, UTB will be applied with 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine.

Procedure: Upper trunk blockProcedure: Diaphragmatic function assessmentProcedure: Cervical plexus blockade

Costoclavicular brachial plexus block

ACTIVE COMPARATOR

In the infraclavicular region, CCBPB will be applied with 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine.

Procedure: Costoclavicular blockProcedure: Diaphragmatic function assessmentProcedure: Cervical plexus blockade

Interventions

Block will be applied to supraclavicular zone by 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine .

Also known as: Upper trunk brachial plexus block
Upper trunk block

Block will be applied to infraclavicular zone by 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine.

Also known as: Costoclavicular brachial plexus block
Costoclavicular brachial plexus block

Diaphragmatic excursion will be assessed under ultrasound immediately before and after regional anesthesia.

Also known as: Detection of diaphragmatic paralysis with ultrasound guidance
Costoclavicular brachial plexus blockUpper trunk block

Block will be applied at thyroid cartilage level via 10 ml % 0.25 bupivacaine.

Also known as: Superficial cervical plexus blockade
Costoclavicular brachial plexus blockUpper trunk block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Association of Anesthesiologists (ASA) physical status I - III
  • BMI 20 to 35 kg / m2
  • Patients scheduled for elective arthroscopic shoulder surgery

You may not qualify if:

  • Patients who refuse to participate in the study,
  • Pre-existing (obstructive or restrictive) lung disease,
  • Coagulopathy,
  • Sepsis,
  • Hepatic or renal insufficiency,
  • Pregnancy
  • Allergy to local anesthetic drugs,
  • Chronic pain condition requiring opioid intake at home,
  • Surgery in the neck or infraclavicular region
  • BMI above 40.
  • History of psychiatric diseases needing treatment.
  • Failure of nerve block performed in the preoperative block room
  • Substance abuse history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakıf University

Istanbul, Fatih, 34093, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Shoulder Pain

Interventions

Cervical Plexus Block

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nerve BlockAnesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Serdar Yeşiltaş, Instructor

    Bezmialem Vakif University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Serdar Yeşiltaş, Instructor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2019

First Posted

December 11, 2019

Study Start

May 10, 2020

Primary Completion

May 1, 2023

Study Completion

June 1, 2023

Last Updated

April 5, 2023

Record last verified: 2023-04

Locations